Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

27.61 +0.56 (+2.07%)
Official Closing Price Updated: 7:00 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 43,733,145
Open 27.17
Bid (Size) 27.54 (400)
Ask (Size) 27.56 (500)
Prev. Close 27.05
Today's Range 27.09 - 27.73
52wk Range 20.91 - 27.69
Shares Outstanding 5,606,688,356
Dividend Yield 6.23%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Thinking About Investing in GLP-1 Stocks? Here Are 3 Things You Need to Know ↗
The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it. 
Via The Motley Fool
News headline image
Is 2026 the Year of Dividend Stocks? These 2 Income-Focused ETFs Have Been Soaring Past the S&P 500 ↗
These funds both pay more than 3% and have been beating the market this year. 
Via The Motley Fool
Topics ETFs Stocks

Performance

YTD
+9.7%
+9.7%
1 Month
+9.3%
+9.3%
3 Month
+13.2%
+13.2%
6 Month
+12.3%
+12.3%
1 Year
+6.7%
+6.7%

More News

Read More
News headline image
CVS Health Navigates a Stormy 2026: Record Revenue Tempered by Medicare Advantage Costs and PBM Turmoil
Via MarketMinute
Topics Economy
News headline image
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
Via Finterra
Topics Economy Intellectual Property
News headline image
The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026
Via Finterra
Topics Artificial Intelligence Economy Fraud
News headline image
Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse
Via Finterra
Topics Economy World Trade
News headline image
Could Eli Lilly Turn Today's GLP‑1 Obesity Boom Into Multi‑Decade, Millionaire‑Maker Gains? ↗
Via The Motley Fool
News headline image
5 Revealing Analyst Questions From Pfizer’s Q4 Earnings Call
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Should You Buy Pfizer's Stock for Its 6.3%-Yielding Dividend? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Healthcare Stocks Paying the Highest Dividends of 2026 ↗
Via The Motley Fool
News headline image
AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Fiscal Brinkmanship: Data Blackout and the DHS Cliff Loom Over Markets After Narrow Funding Deal
Via MarketMinute
Topics Economy Government Immigration
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
Via Finterra
Topics Economy Government Intellectual Property
News headline image
Broad-Based Prosperity: S&P 500 Defies Headwinds with 10.1% Growth as Tech Reclaims Its Crown
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Pops on Q4 Results—But This May Be the Catalyst That Matters Most ↗
Via MarketBeat
News headline image
Trade War 2.0: 25% Tariffs on Chips, Cars, and Medicine Reshape the Global Supply Chain
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
Via MarketMinute
Topics Earnings Economy
News headline image
Pfizer (PFE) Q4 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Pfizer (PFE) Q3 2024 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Pfizer (PFE) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗
Via Stocktwits
Topics Economy Government World Trade
News headline image
Men's Health Network Launches "My Cancer, My Plan" Podcast on World Cancer Day
Via PRLog
Topics Death

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.61
When was Pfizer last traded?
The last trade of Pfizer was at 02/10/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 154.80B
How many shares of Pfizer are outstanding?
Pfizer has 155B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.